FIELD: medicine.
SUBSTANCE: claimed invention relates to field of biotechnology and deals with method of obtaining immunoenzymatic test-system for determination of epitopes of envelope protein of Puumala virus with protective orientation in vaccine preparations against haemorrhagic fever with renal syndrome (HFRS). Characterised method includes obtaining murine monoclonal antibodies, possessing neutralising activity with respect to Puumala virus; sorption of said antibodies on immune panel; separation of IgG from blood serum of HFRS reconvalescents with high titres of specific antibodies to Puumala virus; preparation of conjugate of specific IgG with horse radish peroxidise.
EFFECT: claimed invention makes it possible to detect envelope protein of both live and inactivated Puumala virus with similar accuracy, which serves for control of content of said virus, which is a causative agent of haemorrhagic fever with renal syndrome, in vaccine preparation.
2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCING "HANTA-N" TEST SYSTEM FOR DETERMINING SPECIFIC ACTIVITY OF VACCINE AGAINST HEMORRHAGIC FEVER WITH RENAL SYNDROME | 2012 |
|
RU2590606C2 |
HEMORRHAGIC FEVER AND RENAL SYNDROME CAUSAL VIRUS STRAIN FOR PREPARING VACCINE PREPARATIONS (VERSIONS) | 2009 |
|
RU2423520C1 |
METHOD FOR PRODUCING CULTURAL, POLYVALENT EPIDEMIC HAEMORRHAGIC FEVER DIAGNOSTICUM FOR INDIRECT IMMUNOFLUORESCENCE | 2010 |
|
RU2431148C1 |
METHOD OF PRODUCTION OF RECOMBINANT ANTIGEN G2 OF HANTAVIRUS DOBRAVA IN CELLS OF E coli | 2011 |
|
RU2495938C2 |
VIRUS STRAIN FOR PRODUCING VACCINE DRUGS AGAINST HEMORRHAGIC FEVER WITH RENAL SYNDROME (OPTIONS) | 2018 |
|
RU2683508C1 |
METHOD OF OBTAINING RECOMBINANT ENZYME-LABELLED ANTIGEN G2 OF HANTAVIRUS IN E. coli CELLS AIMED AT ITS APPLICATION IN IMMUNOSORBENT ASSAY IN HFRS DIAGNOSTICS | 2012 |
|
RU2539836C2 |
METHOD OF CHANTA-VIRUS DIAGNOSTICUM PREPARING | 2000 |
|
RU2180754C2 |
METHOD OF OBTAINING RECOMBINANT ANTIGEN G2 OF DOBRAVA HANTAVIRUS IN E.coli CELLS | 2012 |
|
RU2509805C2 |
METHOD FOR PREPARING COMBINED BIVALENT, TISSUE-CULTURE, INACTIVATED, CONCENTRATED, PURIFIED VACCINE FOR PREVENTING HEMORRHAGIC FEVER AND RENAL SYNDROME | 2009 |
|
RU2445117C2 |
pET21-GST-CD RECOMBINANT PLASMID WHICH ENSURES SYNTHESIS AND SECRETION OF Gn ECTODOMAIN OF HANTAAN VIRUS GLYCOPROTEIN, AND BL21(DE3)PLYSE pET21-GST-CD RECOMBINANT ESCHERICHIA COLI STRAIN, PRODUCER OF Gn PROTEIN, ECTODOMAIN OF HANTAAN VIRUS GLYCOPROTEIN | 2023 |
|
RU2809199C1 |
Authors
Dates
2015-10-20—Published
2013-04-10—Filed